Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 162 institutions that hold shares in the stock, with a total of 134 Million shares, which have been reported (via 13F filing form) to have a value of $328 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tpg Gp A, LLC
Fort Worth, TX |
Nov 14, 2024 Q3 2024 |
18,716,306
shares
|
$42.5 Million
1.25% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$37.3 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
8,327,699
shares
|
$18.9 Million
0.0% of portfolio
|
Q3 2024
Added 1.61%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
7,013,083
shares
|
$15.9 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.54%
|
|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
6,896,552
shares
|
$15.7 Million
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Nov 14, 2024 Q3 2024 |
6,202,374
shares
|
$14.1 Million
6.22% of portfolio
|
Q3 2024
New holding
|
|
|
Primecap Management CO
Pasadena, CA |
Nov 08, 2024 Q3 2024 |
5,668,260
shares
|
$12.9 Million
0.01% of portfolio
|
Q3 2024
Reduced 0.03%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
5,039,594
shares
|
$11.4 Million
0.0% of portfolio
|
Q3 2024
Added 105.99%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
4,838,743
shares
|
$11 Million
0.0% of portfolio
|
Q3 2024
Reduced 16.44%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
4,364,300
shares
|
$9.91 Million
0.11% of portfolio
|
Q3 2024
Added 0.12%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
4,087,506
shares
|
$9.28 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.91%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
3,227,104
shares
|
$7.33 Million
0.0% of portfolio
|
Q3 2024
Added 14.43%
|
|
|
Wildcat Capital Management, LLC
|
Nov 08, 2024 Q3 2024 |
2,920,787
shares
|
$6.63 Million
4.0% of portfolio
|
Q2 2024
Added 52.06%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
2,867,750
shares
|
$6.51 Million
0.43% of portfolio
|
Q1 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,797,970
shares
|
$6.35 Million
0.02% of portfolio
|
Q3 2024
Reduced 5.5%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
2,730,480
shares
|
$6.2 Million
0.0% of portfolio
|
Q3 2024
Added 7.05%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,725,000
shares
|
$6.19 Million
0.2% of portfolio
|
Q2 2024
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
2,410,400
shares
|
$5.47 Million
0.02% of portfolio
|
Q3 2024
Added 7.49%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
2,162,603
shares
|
$4.91 Million
0.0% of portfolio
|
Q3 2024
Added 41.34%
|
|
|
Vida Ventures Advisors, LLC
|
Oct 08, 2024 Q3 2024 |
1,798,163
shares
|
$4.08 Million
5.9% of portfolio
|
Q3 2020
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,721,530
shares
|
$3.91 Million
0.0% of portfolio
|
Q3 2024
Reduced 20.19%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
1,634,838
shares
|
$3.71 Million
0.03% of portfolio
|
Q3 2024
Added 461.58%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,500,000
shares
|
$3.41 Million
0.32% of portfolio
|
Q3 2024
Reduced 31.82%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,248,539
shares
|
$2.83 Million
0.0% of portfolio
|
Q3 2024
Added 20.27%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,178,848
shares
|
$2.68 Million
0.0% of portfolio
|
Q3 2024
Added 0.04%
|